GSK plc (GSK)

Revenue Breakdown

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
HIV Revenue	7.80B	7.69B	7.09B
HIV Revenue Growth	1.43%	8.44%	10.01%
Respiratory, Immunology and Inflammation Revenue	3.90B	3.81B	3.30B
Respiratory, Immunology and Inflammation Revenue Growth	2.26%	15.49%	9.06%
Oncology Revenue	2.07B	1.98B	1.41B
Oncology Revenue Growth	4.91%	40.21%	92.89%
Specialty Medicines Revenue	13.77B	13.47B	11.81B
Specialty Medicines Revenue Growth	2.17%	14.09%	15.29%
Shingles Revenue	3.72B	3.56B	3.36B
Shingles Revenue Growth	4.47%	5.77%	-2.38%
Meningitis Revenue	1.57B	1.58B	1.44B
Meningitis Revenue Growth	-0.95%	10.16%	14.05%
Influenza Revenue	312.00M	303.00M	408.00M
Influenza Revenue Growth	2.97%	-25.74%	-19.05%
Other Paediatric & Adult Vaccines Revenue	3.03B	3.12B	3.34B
Other Paediatric & Adult Vaccines Revenue Growth	-2.76%	-6.56%	2.23%
Vaccines Revenue	9.21B	9.16B	9.14B
Vaccines Revenue Growth	0.59%	0.21%	-7.36%
Respiratory Revenue	6.95B	7.07B	7.21B
Respiratory Revenue Growth	-1.64%	-2.01%	5.68%
Other General Medicines Revenue	2.85B	2.97B	3.22B
Other General Medicines Revenue Growth	-3.98%	-7.68%	-5.30%
General Medicines Revenue	9.80B	10.04B	10.43B
General Medicines Revenue Growth	-2.33%	-3.76%	2.04%
Revenue (Total)	32.78B	32.67B	31.38B
Revenue (Total) Growth	0.35%	4.12%	3.46%

Revenue Breakdown 2

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Total Commercial Operations Revenue	32.78B	32.67B	31.38B
Total Commercial Operations Revenue Growth	0.35%	4.12%	3.46%
Revenue (Total)	32.78B	32.67B	31.38B
Revenue (Total) Growth	0.35%	4.12%	3.46%

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
US Revenue	16.84B	16.86B	16.38B
US Revenue Growth	-0.09%	2.90%	3.56%
Europe Revenue	7.87B	7.53B	6.67B
Europe Revenue Growth	4.43%	13.01%	1.55%
International Revenue	8.07B	8.28B	8.33B
International Revenue Growth	-2.49%	-0.61%	4.81%
Revenue (Total)	32.78B	32.67B	31.38B
Revenue (Total) Growth	0.35%	4.12%	3.46%

EBIT

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Commercial Operations Segment Profit	16.49B	16.26B	15.34B
Commercial Operations Segment Profit Growth	1.43%	6.03%	4.63%
Research & Development Segment Profit	-6.33B	-6.25B	-5.85B
Operating Income (Other)	-2.16B	-2.08B	-5.47B
Operating Income (Total)	8.01B	7.93B	4.02B
Operating Income (Total) Growth	0.97%	97.26%	-40.38%

Updated Apr 29, 2026. Data Source: Fiscal.ai.